A detailed history of Group One Trading, L.P. transactions in Cure Vac N.V. stock. As of the latest transaction made, Group One Trading, L.P. holds 79,360 shares of CVAC stock, worth $261,094. This represents 0.01% of its overall portfolio holdings.

Number of Shares
79,360
Previous 37,807 109.91%
Holding current value
$261,094
Previous $114,000 135.96%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.31 - $4.99 $95,987 - $207,349
41,553 Added 109.91%
79,360 $269,000
Q1 2024

May 10, 2024

SELL
$2.94 - $4.34 $44,688 - $65,968
-15,200 Reduced 28.68%
37,807 $114,000
Q4 2023

Feb 14, 2024

BUY
$3.96 - $6.41 $24,140 - $39,075
6,096 Added 12.99%
53,007 $223,000
Q3 2023

Nov 09, 2023

SELL
$6.5 - $10.77 $377 - $624
-58 Reduced 0.12%
46,911 $320,000
Q2 2023

Aug 09, 2023

BUY
$6.69 - $12.25 $52,924 - $96,909
7,911 Added 20.25%
46,969 $489,000
Q1 2023

May 12, 2023

SELL
$6.38 - $12.5 $66,996 - $131,262
-10,501 Reduced 21.19%
39,058 $272,000
Q4 2022

Feb 09, 2023

BUY
$5.75 - $8.5 $7,360 - $10,880
1,280 Added 2.65%
49,559 $298,000
Q3 2022

Nov 09, 2022

SELL
$7.48 - $15.24 $6,545 - $13,335
-875 Reduced 1.78%
48,279 $380,000
Q2 2022

Aug 11, 2022

SELL
$13.18 - $19.41 $849,543 - $1.25 Million
-64,457 Reduced 56.73%
49,154 $669,000
Q1 2022

May 12, 2022

SELL
$14.73 - $35.25 $268,793 - $643,242
-18,248 Reduced 13.84%
113,611 $2.23 Million
Q4 2021

Feb 11, 2022

SELL
$33.72 - $48.22 $2.84 Million - $4.06 Million
-84,154 Reduced 38.96%
131,859 $4.52 Million
Q3 2021

Nov 12, 2021

BUY
$49.26 - $74.5 $10.6 Million - $16.1 Million
216,013 New
216,013 $11.8 Million
Q2 2021

Aug 10, 2021

SELL
$56.91 - $127.53 $4.51 Million - $10.1 Million
-79,300 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$79.79 - $126.29 $4.9 Million - $7.75 Million
61,387 Added 342.7%
79,300 $7.25 Million
Q4 2020

Feb 10, 2021

BUY
$46.76 - $136.27 $837,611 - $2.44 Million
17,913 New
17,913 $1.45 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $617M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.